VT
The startup develops targeted therapeutics for neurological disorders, cancer, and infectious diseases, focusing on conditions such as dementia, peripheral amyloidosis, and Alzheimer's. By utilizing specific drug formulations, the company aims to provide effective treatment options that improve patient outcomes in these critical health areas.
Updated 18 months ago
Funding
$2.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MU
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops targeted therapeutics for neurological disorders, cancer, and infectious diseases, focusing on conditions such as dementia, peripheral amyloidosis, and Alzheimer's. By utilizing specific drug formulations, the company aims to provide effective treatment options that improve patient outcomes in these critical health areas.